Ptc Therapeutics (PTCT) Tax Provisions (2016 - 2025)
Historic Tax Provisions for Ptc Therapeutics (PTCT) over the last 11 years, with Q3 2025 value amounting to -$39.0 million.
- Ptc Therapeutics' Tax Provisions fell 54984.42% to -$39.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.9 million, marking a year-over-year decrease of 4264.7%. This contributed to the annual value of $26.8 million for FY2024, which is 13855.78% up from last year.
- Ptc Therapeutics' Tax Provisions amounted to -$39.0 million in Q3 2025, which was down 54984.42% from -$6.2 million recorded in Q2 2025.
- Over the past 5 years, Ptc Therapeutics' Tax Provisions peaked at $63.3 million during Q1 2025, and registered a low of -$39.0 million during Q3 2025.
- For the 5-year period, Ptc Therapeutics' Tax Provisions averaged around -$2.5 million, with its median value being $451000.0 (2021).
- Within the past 5 years, the most significant YoY rise in Ptc Therapeutics' Tax Provisions was 97206.21% (2022), while the steepest drop was 4960277.78% (2022).
- Quarter analysis of 5 years shows Ptc Therapeutics' Tax Provisions stood at $4.7 million in 2021, then plummeted by 503.78% to -$18.8 million in 2022, then skyrocketed by 93.3% to -$1.3 million in 2023, then crashed by 73.87% to -$2.2 million in 2024, then tumbled by 1680.26% to -$39.0 million in 2025.
- Its last three reported values are -$39.0 million in Q3 2025, -$6.2 million for Q2 2025, and $63.3 million during Q1 2025.